🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A phase 3, randomized, double-blind trial to evaluate the safety and immuno...
Status
Completed
Location
Seishinkai Inoue Hospital
Start Date
2021-06-14
Trial ID
NCT04875533
The purpose of this study is to evaluate the safety and immune response of ...
Status
Completed
Location
University of Rochester
Start Date
2000-11
Trial ID
NCT00133549
Treatments Being Tested
The current study provides data necessary to evaluate the safety and immuno...
Status
Unknown
Location
Multiple Locations
Start Date
2022-01-25
Trial ID
NCT05140720
Treatments Being Tested
Immune response analysis after the combination of PCV13 and PPV23 will lead...
Status
Completed
Location
Multiple Locations
Start Date
2014-12-04
Trial ID
NCT02279589
Treatments Being Tested
Previous studies have demonstrated the immunogenicity and safety of the co-...
Status
Completed
Location
Korea University Ansan Hospital
Start Date
2012-10
Trial ID
NCT02582047
Treatments Being Tested
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01444781
Streptococcus pneumoniae is a major cause of morbidity and mortality in chi...
Status
Unknown
Location
Xiangtan Maternal and Child Health Hospital
Start Date
2022-11-01
Trial ID
NCT05602480
The overall objective of this project is to study the influence of modern a...
Status
Completed
Location
Multiple Locations
Start Date
2016-06-14
Trial ID
NCT03762824
Treatments Being Tested